Figure 2 | Scientific Reports

Figure 2

From: Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model

Figure 2

No difference in Neurological outcome under Rivaroxaban treatment post-ET. (A) Bederson scale score in 30 mg/kg Rivaroxaban-pretreated rats (n = 12) is 2.75 ± 0.18 and diabetic control rats (n = 12) is 2.64 ± 0.20, without significant difference (unpaired t-test, P = 0.70). (B) Garcia scale score in 30 mg/kg Rivaroxaban-pretreated rats (n = 12) is 7.42 ± 0.42 and diabetic control rats (n = 12) is 7.93 ± 0.29, not significantly different (unpaired t-test, P = 0.31).

Back to article page